Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Denali Therapeutics Inc. (DNLI) $552,000 $4,258,045
2024 Denali Therapeutics Inc. (DNLI) $535,600 $4,022,759
2023 Denali Therapeutics Inc. (DNLI) $520,000 $4,169,183
2022 Denali Therapeutics Inc. (DNLI) $500,000 $5,692,052
2021 Denali Therapeutics Inc. (DNLI) $465,129 $6,530,026
2020 Denali Therapeutics Inc. (DNLI) $449,400 $4,203,402
2019 Denali Therapeutics Inc. (DNLI) $428,000 $2,476,628
2018 Denali Therapeutics Inc. (DNLI) $400,000 $3,901,789
2017 Denali Therapeutics Inc. (DNLI) $369,008 $1,076,937

Recent activity

No earnings-call appearances or filed executive changes recorded yet.